Company name: | Astrazeneca Plc |
Company Description: | A group engaged in R&D; manufacture & marketing of prescription pharmaceuticals & biological products for healthcare areas such as cardiovascular; neuroscience; oncology; respiratory & inflammation
|
EPIC: | AZN | Trading Currency: | GBX |
Market Sector: | FE10 | ISIN: | GB0009895292 |
Market Segment: | SET1 | Share Type: | DE |
WWW Address: | http://www.astrazeneca.com/ | Description: | ORD SHS $0.25 |
Industry Sector: | PHARMACEUTICALS & BIOTECHNOLOGY |
Price | Price Change [%] | Bid | Offer | Open | High | Low | Volume |
7,650.00 | 5.0 [0.07] | 7,644.00 | 7,648.00 | 7,689.00 | 7,747.00 | 7,636.00 | 2,475,560 |
Market Cap. [m] | Shares In Issue [m] | Beta | EPS | DPS | PE Ratio | Yield | 52-Wks-Range |
100,360.70 | 1,311.90 | -0.95 | 75.03 | 211.13 | 101.96 | 2.76 | 10,120.00 - 5,871.00 |
Astrazeneca Key Figures
|
Astrazeneca Balance Sheet
 Share Price PerformanceSample Period † | High | Low | 1 week | 7,788.00 | 7,450.00 |
4 weeks | 7,788.00 | 7,217.00 |
12 weeks | 8,799.00 | 7,196.00 |
1 year | 10,120.00 | 5,871.00 |
 Share Price Chart (5 years)
|
Astrazeneca Historic ReturnsPeriod † | Open | Change | % | Open Avg. | Avg. Daily Vol [m] | Total Vol [m] | VWAP | 1 week | 7,480.00 | 170.00 | 2.27 | 7,450.00 | 3.37 | | 7,622.78 |
4 weeks | 7,250.00 | 400.00 | 5.52 | 7,217.00 | 2.75 | | 7,512.32 |
12 weeks | 7,805.00 | -155.00 | -1.99 | 7,196.00 | 2.72 | | 7,800.26 |
26 weeks | 9,331.00 | -1,681.00 | -18.02 | 7,196.00 | 2.10 | | 8,072.38 |
1 year | 7,798.00 | -148.00 | -1.90 | 5,871.00 | 2.38 | | 7,921.82 |
3 years | 5,038.00 | 2,612.00 | 51.85 | 4,544.50 | 2.23 | | 6,747.87 |
5 years | 4,300.00 | 3,350.00 | 77.91 | 3,680.00 | 2.43 | | 5,786.72 |
† periods calculated are whole weeks rather than calendar months | |
|
Astrazeneca Key Management Ratios
|
Astrazeneca Investment Ratios
|
Astrazeneca Financial Ratios
Beta (60-Mnth) | Beta (36-Mnth) | -0.9486 | -2.1709 |
|
Astrazeneca Operating Ratios
|
Astrazeneca DividendsAnnouncement Date | Type | Curr. | Dividend Amount | Period Start | Period End | Ex Date | Record Date | Payment Date | Total Dividend Amount | 14 Feb 2020 | Interim | USX | 190.00 | 31/12/2018 | 31/12/2019 | 27/02/2020 | 28/02/2020 | 30/03/2020 | 280.00 |
25 Jul 2019 | Interim | USX | 90.00 | 31/12/2018 | 31/12/2019 | 08/08/2019 | 09/08/2019 | 09/09/2019 | - |
14 Feb 2019 | Final | USX | 190.00 | 31/12/2017 | 31/12/2018 | 28/02/2019 | 01/03/2019 | 27/03/2019 | 280.00 |
26 Jul 2018 | Interim | USX | 90.00 | 31/12/2017 | 31/12/2018 | 09/08/2018 | 10/08/2018 | 10/09/2018 | - |
02 Feb 2018 | Final | USX | 190.00 | 31/12/2016 | 31/12/2017 | 15/02/2018 | 16/02/2018 | 19/03/2018 | 280.00 |
27 Jul 2017 | Interim | USX | 90.00 | 31/12/2016 | 31/12/2017 | 10/08/2017 | 11/08/2017 | 11/09/2017 | - |
02 Feb 2017 | Final | USX | 190.00 | 31/12/2015 | 31/12/2016 | 16/02/2017 | 17/02/2017 | 20/03/2017 | 280.00 |
28 Jul 2016 | Interim | USX | 90.00 | 31/12/2015 | 31/12/2016 | 11/08/2016 | 12/08/2016 | 12/09/2016 | - |
04 Feb 2016 | Final | USX | 190.00 | 31/12/2014 | 31/12/2015 | 18/02/2016 | 19/02/2016 | 21/03/2016 | 280.00 |
30 Jul 2015 | Interim | USX | 90.00 | 31/12/2014 | 31/12/2015 | 13/08/2015 | 14/08/2015 | 14/09/2015 | - |
05 Feb 2015 | Final | USX | 190.00 | 31/12/2013 | 31/12/2014 | 19/02/2015 | 20/02/2015 | 23/03/2015 | 280.00 |
31 Jul 2014 | Interim | USX | 90.00 | 31/12/2013 | 31/12/2014 | 13/08/2014 | 15/08/2014 | 15/09/2014 | - |
06 Feb 2014 | Final | USX | 190.00 | 31/12/2012 | 31/12/2013 | 19/02/2014 | 21/02/2014 | 24/03/2014 | 280.00 |
01 Aug 2013 | Interim | USX | 90.00 | 31/12/2012 | 31/12/2013 | 14/08/2013 | 16/08/2013 | 16/09/2013 | - |
31 Jan 2013 | Final | USX | 190.00 | 31/12/2011 | 31/12/2012 | 13/02/2013 | 15/02/2013 | 18/03/2013 | 280.00 |
26 Jul 2012 | Interim | USX | 90.00 | 31/12/2011 | 31/12/2012 | 08/08/2012 | 10/08/2012 | 10/09/2012 | - |
02 Feb 2012 | Final | USX | 195.00 | 31/12/2010 | 31/12/2011 | 15/02/2012 | 17/02/2012 | 19/03/2012 | 280.00 |
28 Jul 2011 | Interim | USX | 85.00 | 31/12/2010 | 31/12/2011 | 03/08/2011 | 05/08/2011 | 12/09/2011 | - |
27 Jan 2011 | Final | USX | 185.00 | 31/12/2009 | 31/12/2010 | 02/02/2011 | 04/02/2011 | 14/03/2011 | 255.00 |
29 Jul 2010 | Interim | USX | 70.00 | 31/12/2009 | 31/12/2010 | 02/08/2010 | 04/08/2010 | 13/09/2010 | - |
28 Jan 2010 | Final | USX | 171.00 | 31/12/2008 | 31/12/2009 | 03/02/2010 | 05/02/2010 | 15/03/2010 | 230.00 |
30 Jul 2009 | Interim | USX | 59.00 | 30/12/2008 | 30/06/2009 | 05/08/2009 | 07/08/2009 | 14/09/2009 | - |
29 Jan 2009 | Final | USX | 150.00 | 31/12/2007 | 31/12/2008 | 04/02/2009 | 06/02/2009 | 16/03/2009 | 205.00 |
31 Jul 2008 | Interim | USX | 55.00 | 30/12/2007 | 30/06/2008 | 08/08/2008 | 06/08/2008 | 15/09/2008 | - |
31 Jan 2008 | Final | USX | 135.00 | 31/12/2006 | 31/12/2007 | 06/02/2008 | 08/02/2008 | 17/03/2008 | 187.00 |
26 Jul 2007 | Interim | USX | 52.00 | 30/06/2006 | 30/06/2007 | 08/08/2007 | 10/08/2007 | 17/09/2007 | - |
01 Feb 2007 | Final | USX | 123.00 | 31/12/2005 | 31/12/2006 | 07/02/2007 | 09/02/2007 | 19/03/2007 | 172.00 |
27 Jul 2006 | Interim | USX | 49.00 | 30/12/2005 | 30/06/2006 | 09/08/2006 | 11/08/2006 | 18/09/2006 | - |
01 Feb 2006 | Final | USX | 92.00 | 31/12/2004 | 31/12/2005 | 08/02/2006 | 10/02/2006 | 20/03/2006 | 130.00 |
29 Jul 2005 | Interim | USX | 38.00 | 30/12/2004 | 30/06/2005 | 10/08/2005 | 12/08/2005 | 19/09/2005 | - |
27 Jan 2005 | Final | USX | 64.50 | 31/12/2003 | 31/12/2004 | 09/02/2005 | 11/02/2005 | 21/03/2005 | 94.00 |
22 Jul 2004 | Interim | USX | 29.50 | 30/12/2003 | 30/06/2004 | 11/08/2004 | 13/08/2004 | 20/09/2004 | - |
29 Jan 2004 | Final | USX | 54.00 | 31/12/2002 | 31/12/2003 | 18/02/2004 | 20/02/2004 | 06/04/2004 | 79.50 |
24 Jul 2003 | Interim | USX | 25.50 | 30/12/2002 | 30/06/2003 | 20/08/2003 | 22/08/2003 | 06/10/2003 | - |
30 Jan 2003 | Final | USX | 47.00 | 31/12/2001 | 31/12/2002 | 19/02/2003 | 21/02/2003 | 07/04/2003 | 70.00 |
25 Jul 2002 | Interim | USX | 23.00 | 30/12/2001 | 30/06/2002 | 21/08/2002 | 23/08/2002 | 07/10/2002 | - |
31 Jan 2002 | Final | USX | 47.00 | 31/12/2000 | 31/12/2001 | 20/02/2002 | 22/02/2002 | 08/04/2002 | 70.00 |
26 Jul 2001 | Interim | USX | 23.00 | 30/12/2000 | 30/06/2001 | 22/08/2001 | 24/08/2001 | 05/10/2001 | - |
08 Feb 2001 | Final | USX | 47.00 | 31/12/1999 | 31/12/2000 | 21/02/2001 | 23/02/2001 | 09/04/2001 | 70.00 |
01 Aug 2000 | Interim | USX | 23.00 | 30/12/1999 | 30/06/2000 | 04/09/2000 | 08/09/2000 | 23/10/2000 | - |
24 Feb 2000 | Final | USX | 47.00 | 31/12/1998 | 31/12/1999 | 06/03/2000 | 10/03/2000 | 17/04/2000 | 70.00 |
03 Aug 1999 | Interim | USX | 23.00 | 30/12/1998 | 30/06/1999 | 06/09/1999 | 10/09/1999 | 25/10/1999 | - |
|
|
Astrazeneca Fundamentals |
| 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
turnover | 23,002.00 | 100.00% |  | 22,465.00 | 100.00% |  | 22,090.00 | 100.00% |  | 24,384.00 | 100.00% | m |
pre tax profit | 3,552.00 | 15.44% |  | 2,227.00 | 9.91% |  | 1,993.00 | 9.02% |  | 1,548.00 | 6.35% | m |
attributable profit | 3,499.00 | 15.21% |  | 3,001.00 | 13.36% |  | 2,155.00 | 9.76% |  | 1,335.00 | 5.47% | m |
retained profit | -62.00 | -0.27% |  | -518.00 | -2.31% |  | -1,329.00 | -6.02% |  | -2,257.00 | -9.26% | m |
eps - basic | 277.00 | |  | 237.00 | |  | 170.00 | |  | 103.00 | |  |
eps - diluted | 277.00 | |  | 237.00 | |  | 170.00 | |  | 103.00 | |  |
dividends per share | 280.00 | |  | 280.00 | |  | 280.00 | |  | 280.00 | |  |
| | | | | | | | | | | | |
|
Astrazeneca Balance Sheet | 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
 |   |  |   |  |   |  |   |  |
|
| 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
ASSETS | | |  | | |  | | |  | | |  |
fixed assets | 6,848.00 | 10.95% |  | 7,615.00 | 12.02% |  | 7,421.00 | 12.24% |  | 7,688.00 | 12.53% | m |
intangibles | 39,244.00 | 62.76% |  | 38,013.00 | 60.00% |  | 33,666.00 | 55.51% |  | 33,148.00 | 54.01% | m |
fixed investments | 2,080.00 | 3.33% |  | 2,798.00 | 4.42% |  | 2,186.00 | 3.60% |  | 2,405.00 | 3.92% | m |
current assets - other | - | -% |  | - | -% |  | - | -% |  | 70.00 | 0.11% | m |
stocks | 2,334.00 | 3.73% |  | 3,035.00 | 4.79% |  | 2,890.00 | 4.76% |  | 3,193.00 | 5.20% | m |
debtors | 7,002.00 | 11.20% |  | 8,569.00 | 13.53% |  | 9,657.00 | 15.92% |  | 9,504.00 | 15.48% | m |
cash & securities | 5,018.00 | 8.03% |  | 3,324.00 | 5.25% |  | 4,831.00 | 7.97% |  | 5,369.00 | 8.75% | m |
 |
TOTAL | 62,526.00 | 100% |  | 63,354.00 | 100% |  | 60,651.00 | 100% |  | 61,377.00 | 100% | m |
|
LIABILITIES | | | | | | | | | | | | |
creditors - short | 15,256.00 | 24.40% |  | 16,383.00 | 25.86% |  | 16,292.00 | 26.86% |  | 18,117.00 | 29.52% | m |
creditors - long | 30,601.00 | 48.94% |  | 30,329.00 | 47.87% |  | 30,315.00 | 49.98% |  | 28,664.00 | 46.70% | m |
creditors - other | - | -% |  | - | -% |  | - | -% |  | - | -% | m |
subordinated loans | - | -% |  | - | -% |  | - | -% |  | - | -% | m |
insurance funds | - | -% |  | - | -% |  | - | -% |  | - | -% | m |
|
TOTAL | 45,857.00 | 73.34% |  | 46,712.00 | 73.73% |  | 46,607.00 | 76.84% |  | 46,781.00 | 76.22% | m |
|
EQUITY | | | | | | | | | | | | |
ord cap, reserves | 14,854.00 | 23.76% |  | 14,960.00 | 23.61% |  | 12,468.00 | 20.56% |  | 13,127.00 | 21.39% | m |
prefs, minorities | 1,815.00 | 2.90% |  | 1,682.00 | 2.65% |  | 1,576.00 | 2.60% |  | 1,469.00 | 2.39% | m |
|
TOTAL | 16,669.00 | 26.66% |  | 16,642.00 | 26.27% |  | 14,044.00 | 23.16% |  | 14,596.00 | 23.78% | m |
|
OTHER | | | | | | | | | | | | |
NAV Basic | - | |  | - | |  | - | |  | - | |  |
NAV Diluted | - | |  | - | |  | - | |  | - | |  |
|
Astrazeneca Cash Flow Statement | 31 Dec 2016 (USD) | | 31 Dec 2017 (USD) | | 31 Dec 2018 (USD) | | 31 Dec 2019 (USD) | |
Operating CF | 4,145.00 | | 3,578.00 | | 2,618.00 | | 2,969.00 | m |
Pre-Financing CF | 176.00 | | 1,250.00 | | 3,581.00 | | 2,312.00 | m |
Retained CF | -1,148.00 | | -1,686.00 | | 1,537.00 | | 547.00 | m |
| | | | | | | | |
| Astrazeneca Brokers
| | | | |
|
|
|